Dale Gillham's photo, and wording 'Words from Wealth Within's Chief Analyst Dale Gillham.

Dale Gillham’s weekly wrap: Will FDA tick give Mesoblast a boost?

The sellers finally stepped in this week to push the All Ordinaries Index down more than…
Stethoscope and gavel on doctor's desk.

Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%

Mesoblast shares fell -4.45% in the first hour of trades on Tuesday as the company announced…